Clinical Trials by Cancer Types

Stony Brook Cancer Center has over 100 trials that are currently open for patients who meet the criteria. With disease focuses from gastrointestinal cancers, to breast cancer, to gynecologic cancer to hematologic malignancies, Cancer Center physicians and Clinical Trials staff will work with you to ensure that you are given all of the information about a trial that is beneficial for you. 

Find a Trial

Click here to find a clinical trial for your type of cancer on the cancer group that you are interested in. 
 

Spotlight on Clinical Trials

Clinical Trial NCT04398745

A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK2857916 Monotherapy in Participants with Relapsed or Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Renal Function (DREAMM 12)

Disease Group:  Hematologic Malignancy

View Trial Details >

Clinical Trial NCT02914938

A Three-Arm Study of ME-401 Monotherapy in Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Follicular Lymphoma (FL), of ME-401 in Combination with Rituximab in Subjects with Relapsed/Refractory CLL/SLL or B-cell Non-Hodgkin s Lymphoma (NHL), and of ME-401 in Combination with Zanubrutinib in Subjects with Relapsed/Refractory CLL/SLL or B-cell NHL

Disease Group:  Hematologic Malignancy; Hematology Oncology

View Trial Details >

Clinical Trial NCT04088786

Phase I trial of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy with Nanoliposomal Irinotecan in Patients with Peritoneal Surface Cancers

Disease Group:  Gastrointestinal

View Trial Details >

Clinical Trial NCT03829540

A Phase 1, Multicenter Study of CD4- Directed Chimeric Antigen Receptor Engineered T-Cells (CD4CAR) in Patients with Relapsed or Refractory T-Cell Leukemia and Lymphoma

Disease Group:  Hematologic Malignancy

View Trial Details >